N@N

Obagi Medical Products to Present at the 31st Annual Canaccord Global Growth Conference

^{Published on 2011-07-20 14:56:20 - Market Wire}
 

LONG BEACH, Calif.--([ BUSINESS WIRE ])--Obagi Medical Products, Inc. (NASDAQ: OMPI), a leader in topical aesthetic and therapeutic skin health systems, today announced that Preston Romm, the Companya™s Chief Financial Officer and EVP, Finance, Operations and Administration, will present a corporate overview at the 31^st Annual Canaccord Global Growth Conference to be held at the InterContinental Boston Hotel in Boston, Massachusetts. The presentation will take place at 2:30 p.m. (EST) on Thursday, August 11, 2011.

A live webcast of the presentation will be available via the internet by visiting the Investor Relations section of the Company's web site at [ www.obagi.com ]. The archived presentation will be available on the web site for 30 days.

About Obagi Medical Products, Inc.

Obagi Medical Products is a specialty pharmaceutical company that develops, markets and sells, and is a leading provider of, proprietary topical aesthetic and therapeutic prescription-strength skin care systems in the physician-dispensed market. Using its Penetrating Therapeuticsa" technologies, Obagi Medical's products are designed to improve penetration of agents across the skin barrier for common and visible skin conditions in adult skin including premature aging, photodamage, hyperpigmentation (irregular or patchy discoloration of the skin), acne, sun damage, rosacea, and soft tissue deficits, such as fine lines and wrinkles. Obagi Medical's portfolio, which includes cosmetic, over-the-counter and prescription products, including 4% hydroquinone, is sold and promoted only through physician offices and requires education by a physician on proper use. The history of Obagi's skin care product introductions is as follows: Obagi Nu-Derm®, Obagi-C® Rx (a prescription-strength vitamin C and hydroquinone system), Obagi® Professional-C (a line of highly stable vitamin C serums), Obagi Condition &Enhance® for use with cosmetic procedures to enhance patient outcomes and satisfaction, Obagi ELASTIderm® Eye Treatment and Obagi CLENZIderm® M.D. acne therapeutic systems, a formulation of Obagi CLENZIderm M.D. Systems for normal to dry skin, and Obagi ELASTIderm D©colletage System, Obagi Rosaclear® System, Obagi ELASTILasha" Eyelash Solution, Obagi Blue Peel RADIANCE^TM, and Nu-Derm® Sun Shield SPF 50. Visit [ www.obagi.com ] for information.